1 Like
Hi @Nass,
Thanks for sharing. This has been covered recently here:
First gene editing candidate for HBV
Precision BioSciences Announces Initial Safety and Antiviral Activity.
Both topics talks about the same company and product. Thanks, Bansah1
3 Likes